GLUE vs TJX · rev $123.7M vs P/E 32, rev $29.50B
Monte Rosa Therapeutics Inc (GLUE) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
GLUE currently screens at market cap $1.56B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the GLUE and TJX stock pages for the full models.
Not investment advice.